Skip to content
    Time BioVentures logo

    Time BioVentures

    Los Angeles, California, United StatesFounded 2020
    www.timebioventures.comLinkedIn
    Biotech & Life SciencesHealthcare

    Time BioVentures is an early-stage life sciences and healthcare venture capital firm based in Los Angeles, California. The firm finances entrepreneurs developing game-changing technologies in therapeutics, diagnostics, and other healthcare innovations.

    55% of their portfolio is in Healthcare. Deal activity decreased year-over-year (1 deal in the last 12 months vs 4 prior). Average disclosed round size is $52.7M (across 21 rounds with reported amounts).

    Find people at Time BioVentures on Goldilocks AI

    Portfolio

    15

    Fund Size

    $100M

    Top Stage

    Series A

    Last 12 Mo

    1

    Team

    PM

    Paul McEwan

    25+ years of experience in the life science tools space as both an entrepreneur and investor. Co-founder of life science tools companies Agencourt Bioscience, Agencourt Personal Genomics, and Kapa Biosystems, which generated a combined exit value of $700M.

    Ryan Moriarty

    Ryan Moriarty

    Leveraging an eclectic background in education technology and software M&A, Ryan drives firm investment operations, LP communications, and portfolio management.

    Tim Wright, MD

    Tim Wright, MD

    Physician-scientist and one of the world’s most accomplished drug developers, having brought 20+ groundbreaking therapeutics to the market.

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    22 investments
    CompanyRoundAmountDate
    Waypoint Bio logoWaypoint BioSeries A$20MJun 2026
    Commons Clinic logoCommons ClinicSeries B$26MJun 2025
    Phantom Neuro logoPhantom NeuroSeries A$19MApr 2025
    Conceivable Life Sciences logoConceivable Life SciencesSeries A$18MJan 2025
    Commons logoCommonsSeries B$26MJan 2025
    Phantom Neuro logoPhantom NeuroSeries A$19MJan 2025
    Rivermark Medical logoRivermark MedicalSeries C$30MOct 2024
    BBrightside HealthSeries C$33MMar 2024
    Commons Clinic logoCommons ClinicSeries A$19.5MOct 2023
    BillionToOne logoBillionToOneSeries C$48.5MDec 2022
    Phantom Neuro logoPhantom NeuroSeed$6MOct 2022
    BillionToOne logoBillionToOneSeries C$125MMar 2022
    Brightside logoBrightsideSeries B$50MJan 2022
    NanoMosaic logoNanoMosaicSeries A$40.8MDec 2021
    Deepsight Technology logoDeepsight TechnologySeries A$25MOct 2021
    Iterative Scopes logoIterative ScopesSeries A$30MAug 2021
    Neuralink logoNeuralinkSeries C$205MJul 2021
    Iterative Scopes logoIterative ScopesUnknown—Dec 2020
    Iterative Scopes logoIterative ScopesSeed$5.2MJan 2020
    Iterative Health logoIterative HealthSeed$13.5M—
    AdvanCell logoAdvanCellSeries D$315M—
    Brightside logoBrightsideSeries C$33M—

    Top Co-Investors

    Hummingbird Ventures3 shared
    Insight Partners3 shared
    RA Capital Management3 shared
    Floating Point3 shared
    Courtside Ventures3 shared
    ACME Capital3 shared
    Breakout Ventures3 shared
    Draper Associates3 shared
    LionBird3 shared
    S323 shared
    Triventures3 shared
    Mousse Partners3 shared
    Adams Street Partners2 shared
    Fifty Years2 shared
    Neotribe Ventures2 shared
    Baillie Gifford2 shared
    Libertus Capital2 shared
    Norwest Venture Partners2 shared
    SV Health Investors2 shared
    SteelSky Ventures2 shared

    Last updated: 7 October 2026